PAP Therapy Sleep Apnea and Exercise

Obstructive Sleep Apnea Clinical Trial

Official title:

Effects of Positive Airway Pressure Therapy on Exercise Parameters in Obstructive Sleep Apnea

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01786291
• Other study ID #: uyku-cpet-1
• Status: Completed
• Phase: N/A
• First received: February 5, 2013
• Last updated: February 6, 2013
• Start date: May 2010
• Est. completion date: July 2011

Study information

• Verified date: February 2013
• Source: University of Gaziantep
• Contact: n/a
• Is FDA regulated: No
• Health authority: Turkey: Ministry of Health
• Study type: Observational

Clinical Trial Summary

Positive airway pressure (PAP) therapy is generally offered to patients with obstructive sleep apnea. The investigators suggest that beneficial effects of PAP therapy is by preventing apneas and therefore reducing cardiac and pulmonary morbidities. The investigators sought to verify this by assessing cardiac and pulmonary function during exercise.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 65
• Est. completion date: July 2011
• Est. primary completion date: July 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• obstructive sleep apnea diagnosed by polysomnography

• CPAP therapy indicated

Exclusion Criteria:

• obstructive or restrictive lung disease

• cardiac failure

• acute coronary syndrome

• inability to cycle

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Apnea
• Obstructive Sleep Apnea
• Sleep Apnea Syndromes
• Sleep Apnea, Obstructive

Locations

Country	Name	City	State
Turkey	University of Gaziantep, Faculty of Medicine, Dept. of Pulmonary Diseases	Gaziantep

Sponsors (1)

Lead Sponsor	Collaborator
University of Gaziantep

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	peak oxygen uptake		30-60 days	No
Secondary	ventilatory equivalent for carbon dioxide at anaerobic threshold		30-60 days	No